Aspira in the News

We are pleased to announce that Aspira Pathlab & Diagnostics Limited has been admitted to trade in the BSE under direct listing.

December 6, 2017

Aspira Pathlab and Diagnostics are now listed on BSE

Dr. Chaitali Nikam’s abstract has been submitted, accepted and presented at the 27th ECCMID, the European Congress of Clinical Microbiology and Infectious Diseases, which took place in Vienna, Austria, 22 – 25 April 2017

Aspira Pathlab and Diagnostic Limited launched India’s first fully automated Aptio Automation track with multidiscipline modalities, with the support of its partner Siemens Healthineers. The new track will enable Aspira to perform all routine hematology, biochemistry and immunoassay tests with a comprehensive selection of pre- and post-analytical modules that automate sample loading, preparation, and handling so as to free laboratory staff from time-consuming, low-value tasks.